Clinical Trials Logo

Human Papilloma Virus clinical trials

View clinical trials related to Human Papilloma Virus.

Filter by:

NCT ID: NCT06436274 Not yet recruiting - Hiv Clinical Trials

Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

HOPE II
Start date: September 2024
Phase: Phase 4
Study type: Interventional

The Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living with HIV: A Prospective, Individual, Double-Blind, Randomized Controlled Study is evaluating immediate or delayed single-dose nonavalent HPV vaccination among women living with HIV who received one HPV vaccination prior to HIV diagnosis.

NCT ID: NCT06414057 Not yet recruiting - Clinical trials for Human Papilloma Virus

HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

Start date: June 1, 2024
Phase:
Study type: Observational
Read more »
NCT ID: NCT06367699 Not yet recruiting - Clinical trials for Human Papilloma Virus

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV) Clinical Trial

Start date: June 2024
Phase: N/A
Study type: Interventional

The objective of this study is to assess the use of and satisfaction with the ECA-HPV intervention over a 16-month period, its ability to increase HPV vaccination, and the comparative effectiveness of clinic notification and adolescent ECA components on these factors.

NCT ID: NCT06255938 Not yet recruiting - Clinical trials for Human Papilloma Virus

Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence

Start date: February 2024
Phase:
Study type: Observational

By a prospective single center cohort study in the Sexual Assault Care Center (SACC) of the CHU (Centre Hospitalier universitaire) Saint Pierre in Brussels, we would like to : - to evaluate the prevalence of HPV infections in the population of women over 15 years old admitted for rape - to determine the prevalence of HPV and the clearance in HPV-vaccinated and unvaccinated patients

NCT ID: NCT06233331 Not yet recruiting - Clinical trials for Human Immunodeficiency Virus

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Start date: August 2024
Phase: Phase 1
Study type: Interventional

The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main questions it aims to answer are: - The maximum tolerated dose of ACU-D1 - Safety and tolerability of topical ACU-D1 - Whether topical ACU-D1 induces p53 and p53-mediated downstream signaling (including p21 induction) in HPV-related lesions - Whether topical ACU-D1 enhances markers of immunity in HPV-infected HIV-positive individuals Participants will be asked - To apply ACU-D1 on the lesions twice daily for 4 weeks - 3 biopsies will be performed at the screening and 3 at the end of 4 weeks.

NCT ID: NCT06229353 Not yet recruiting - Clinical trials for Human Papilloma Virus

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department

Start date: September 2024
Phase:
Study type: Observational

To determine if the emergency department (ED) setting offers a viable space for improving HPV vaccination coverage among 18 to 45-year-old adults who have not yet received human papilloma virus (HPV) vaccination or who did not complete the vaccine series. This study will develop, pilot and evaluate an ED-based HPV vaccination protocol and program for ED patients aged 18-26 (for whom catch-up HPV vaccination is routinely recommended by the CDC) and separately for patients aged 27-45 (for whom it may be recommended under shared decision making, SDM).

NCT ID: NCT06205511 Recruiting - Clinical trials for Human Immunodeficiency Virus

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

SWISH
Start date: April 1, 2023
Phase:
Study type: Observational

The study will evaluate 300 people living with HIV that attend the Vivent Clinic for HIV care. We will characterize our population and include age, race/ethnicity, sex at birth, tobacco use, alcohol use, other comorbidities, HPV vaccination status, other HPV disease, and lab values such as CD4 count and HIV viral load. We will compare results between participants who are HPV positive and negative. We will also evaluate the relationship between HPV oral infections and lesions and the variables above to better understand possible predictors of HPV infections and lesions.

NCT ID: NCT06161727 Completed - Clinical trials for Human Papilloma Virus

Detection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Treatment With IVF/ICSI.

Start date: January 1, 2023
Phase:
Study type: Observational
Read more »
NCT ID: NCT06154239 Active, not recruiting - Bacterial Vaginosis Clinical Trials

Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views

STAMP
Start date: January 15, 2024
Phase: N/A
Study type: Interventional

Diagnostic trial comparing the diagnostic accuracy of the DAYE Diagnostic Tampon (DDT) with a vaginal swab (self-collected and clinician taken).

NCT ID: NCT05996796 Completed - Cervical Cancer Clinical Trials

Dry Run of the ScreenUrSelf Trial

Start date: April 10, 2023
Phase: N/A
Study type: Interventional

The proposed study is the Dry Run preceding the ScreenUrSelf trial.